Correlation Between Richmond Vanadium and Medical Developments

Can any of the company-specific risk be diversified away by investing in both Richmond Vanadium and Medical Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Richmond Vanadium and Medical Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Richmond Vanadium Technology and Medical Developments International, you can compare the effects of market volatilities on Richmond Vanadium and Medical Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Richmond Vanadium with a short position of Medical Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Richmond Vanadium and Medical Developments.

Diversification Opportunities for Richmond Vanadium and Medical Developments

0.82

Correlation Coefficient

Richmond Vanadium  Medical Developments

Very poor diversification

The 3 months correlation between Richmond and Medical is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Richmond Vanadium Technology and Medical Developments Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Developments and Richmond Vanadium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Richmond Vanadium Technology are associated (or correlated) with Medical Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Developments has no effect on the direction of Richmond Vanadium i.e., Richmond Vanadium and Medical Developments go up and down completely randomly.

Pair Corralation between Richmond Vanadium and Medical Developments

Assuming the 90 days trading horizon Richmond Vanadium Technology is expected to under-perform the Medical Developments. In addition to that, Richmond Vanadium is 3.11 times more volatile than Medical Developments International. It trades about -0.11 of its total potential returns per unit of risk. Medical Developments International is currently generating about 0.01 per unit of volatility. If you would invest  42.00  in Medical Developments International on October 5, 2024 and sell it today you would earn a total of  0.00  from holding Medical Developments International or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Richmond Vanadium Technology  vs.  Medical Developments Internati

Richmond Vanadium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Medical Developments

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Medical Developments is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Richmond Vanadium and Medical Developments

The main advantage of trading using opposite Richmond Vanadium and Medical Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Richmond Vanadium position performs unexpectedly, Medical Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will offset losses from the drop in Medical Developments' long position.

The idea behind Richmond Vanadium Technology and Medical Developments International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.